Protara Announces Pricing of $75 Million Public Offering
Protara Announces Pricing of $75 Million Public Offering GlobeNewswire December 05, 2025 NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the pricing of its underwritten public offering of 13,043,479 shares of its common […]